Gilead Sciences will lose its longtime CFO Robin Washington in March 2020, according to Endpoints News.
Pharmacy
CVS Health is closing 46 stores it said are underperforming, according to Business Insider.
The 10 most popular drugs during the first quarter of 2019 are all generics that cost less than $30 for a one-month supply, according to GoodRx's inaugural quarterly report, an in-depth analysis on drug prices and fill rates in the…
Despite pressure from a prominent hedge fund to strip Allergan CEO Brent Saunders of his chairman duties, Allergan shareholders rejected a proposal that would have immediately split the roles of chairman and CEO, according to Reuters.
US WorldMeds, a pharmaceutical company based in Louisville, Ky., will pay $17.5 million to resolve allegations that it paid kickbacks to patients and physicians to improperly boost prescriptions for two of its drugs.
Walgreens has launched a program to train pharmacists and pharmacy staff to better identify mental health and substance abuse issues in their patients.
Twenty seven hospitals in West Virginia have sued opioid manufacturers, distributors and dispensers, accusing the companies of fueling the opioid crisis by using false marketing claims and unregulated shipping mechanisms, according to the Williamson Daily News.
In the first full quarter since CVS Health closed its $70 billion acquisition of health insurer Aetna, CVS saw its net income increase 43 percent to $1.42 billion, up from $998 million the same period a year earlier, according to…
Pharma giant Merck will restructure its manufacturing and supply network, which will include facility closures and layoffs that will cost up to $1.2 billion to implement, according to Endpoints News.
AmEx Pharmacy is recalling one lot of Bevacizumab injectable, used to treat macular degeneration and diabetic retinopathy, due to a defective delivery system that has resulted in two adverse events.